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OX40 controls effector CD4+ T-cell expansion,
not follicular T helper cell generation in acute
Listeria infection
Clare L. Marriott1, Emma C. Mackley1, Cristina Ferreira2,
Marc Veldhoen2, Hideo Yagita3 and David R. Withers1
1 MRC Centre for Immune Regulation, Institute for Biomedical Research, College of Medical
and Dental Sciences, University of Birmingham, Birmingham, United Kingdom
2 Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom
3 Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan
To investigate the importance of OX40 signals for physiological CD4+ T-cell responses, an
endogenous antigen-specific population of CD4+ T cells that recognise the 2W1S peptide
was assessed and temporal control of OX40 signals was achieved using blocking or ago-
nistic antibodies (Abs) in vivo. Following infection with Listeria monocytogenes expressing
2W1S peptide, OX40 was briefly expressed by the responding 2W1S-specific CD4+ T cells,
but only on a subset that co-expressed effector cell markers. This population was specif-
ically expanded by Ab-ligation of OX40 during priming, which also caused skewing of
the memory response towards effector memory cells. Strikingly, this greatly enhanced
effector response was accompanied by the loss of T follicular helper (TFH) cells and ger-
minal centres. Mice deficient in OX40 and CD30 showed normal generation of TFH cells
but impaired numbers of 2W1S-specific effector cells. OX40 was not expressed by 2W1S-
specific memory cells, although it was rapidly up-regulated upon challenge whereupon
Ab-ligation of OX40 specifically affected the effector subset. In summary, these data indi-
cate that for CD4+ T cells, OX40 signals are important for generation of effector T cells
rather than TFH cells in this response to acute bacterial infection.
Keywords: CD4+ T cells  Costimulation  Germinal centre  Memory  OX40
 Additional supporting information may be found in the online version of this article at thepublisher’s web-site
Introduction
Secondary lymphoid tissue supports the adaptive immune
responses that provide effector cells to clear danger whilst also
generating memory cells that establish protection for the future.
Whilst peptide:MHC complexes and B7 family member costim-
ulation are critical for productive T-cell responses, members of
the TNF receptor superfamily are also involved. Amongst the TNF
Correspondence: Dr. David R. Withers
e-mail: d.withers@bham.ac.uk
receptor superfamily, OX40 is a key determinant for the success
of T-cell responses [1, 2]. Expression of OX40 is absent on naive
T cells, but rapidly expressed upon activation although reportedly
only maintained for a further 3–4 days [1–3]. Signalling through
OX40 was found to inhibit apoptotic pathways through expres-
sion of survivin [4] and Bcl-2 family members, tipping the balance
in favour of enhanced survival and thus aiding clonal expansion
[5]. Consistent with this, OX40−/− mice show impaired CD4+
T-cell responses, with reduced numbers of antigen-specific CD4+
T cells late in the primary response and the memory cell
compartment is greatly reduced [6, 7]. Mice deficient in both
C© 2014 The Authors. European Journal of Immunology published by WILEY-VCH Verlag GmbH & Co.
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OX40 and CD30 show even more impaired CD4+ T-cell responses
and loss of memory cells, indicating redundancy due to shared
signalling pathways [8, 9]. Provision of agonistic anti-OX40
antibodies (Abs) during a primary response resulted in greatly
expanded numbers of antigen-specific CD4+ T cells and a larger
memory cell compartment [6].
Expression of OX40 has been reported on memory pheno-
type (CD44hiCD62L−) CD4+ T cells within the spleen as well as
on memory TCR transgenic cells [8], suggesting that OX40 sig-
nalling may also be important for memory cell survival. Provision
of OX40L by ROR-γ+ innate lymphoid cells (ILCs), which constitu-
tively express this molecule, has been proposed to explain the loss
of memory CD4+ T cells in mice lacking these cells [10]. T follicu-
lar helper (TFH) cells have also been described as OX40+ [11], at
least in some situations [12] and OX40 expression is thought to be
linked to their generation [11]. Treg cells constitutively express
OX40 although the functional consequences of this in vivo are not
completely clear. In studies with OX40−/− Treg cells, it is difficult
to dissect impaired survival with impaired suppressive function in
vivo [13, 14].
Whilst a wealth of experiments on the importance of OX40 for
T-cell responses have been performed, antigen-specific responses
have used monoclonal TCR transgenic T cells [5, 8], transferred
in numbers thousands of times greater than a natural antigen-
specific naive T-cell pool, a methodology that can alter the sur-
vival kinetics [15]. In this study, we have analysed the response
of an endogenous polyclonal population, with the aim to test in
vivo when exactly OX40 was expressed, by what T-cell subsets and
what the in vivo consequences of ligating or blocking this receptor
were. We show that ligation of OX40, which is expressed princi-
pally by effector CD4+ T cells during priming, dramatically skewed
the CD4+ T-cell response towards the formation of effector cells.
Crucially, this occurred at the expense of TFH cells, resulting in a
loss of germinal centres (GCs). Combined, these data clarify the
role of OX40 signals for a physiological cohort of antigen-specific
CD4+ T cells during an acute bacterial infection.
Results
Antigen-specific memory CD4+ T-cell survival is not
impaired by blocking OX40L Abs
Signals through OX40 are clearly important for the survival
of CD4+ T cells after priming [5], however, whether they are
important for the continued survival of formed memory cells is
controversial [2]. We sought to investigate the importance of
OX40 signals for the survival of an endogenous antigen-specific
memory cell pool, using the well-characterised response to an
attenuated Listeria monocytogenes strain expressing the 2W1S pep-
tide (Lm-2W) [16]. In this response, the memory phase occurs
from 3–4 weeks post-infection, after rapid clearance of the bacte-
ria. Therefore, WT mice were immunised with Lm-2W and after 4
weeks given twiceweekly injections of anti-OX40L (or control) Abs
for a further 28 days. At this point, numbers of CD44hi 2W1S:I-Ab+
CD4+ T cells were enumerated (Fig. 1A). Whilst there was a mod-
est reduction in the number of CD44hi2W1S:I-Ab+CD4+ T cells
recovered from the control and treated mice, this difference was
not significant (Fig. 1B; WT vs. OX40L: p = 0.2973; median for
control: 6794, anti-OX40L: 4509).
Heterogeneous expression of OX40 by 2W1S:I-Ab+
CD4+ T cells
Given that the survival of 2W1S-specific memory T cells was not
significantly impaired by anti-OX40L Abs, expression of OX40
by 2W1S-specific CD4+ T cells during the response to Lm-2W
infection was assessed, with total CD4+ Treg cells used as a pos-
itive control for OX40 detection (Fig. 1C). Although only a small
number of 2W1S:I-Ab+CD4+ T cells were detectable 2 days post-
infection (dpi) with Lm-2W, these lacked expression of OX40
(Fig. 1C). By 3 dpi, OX40 expression was detected on the
2W1S:I-Ab+ CD4+ T cells, however<50% of the cells were OX40+
(Fig. 1C and D) and this represented the peak of detectable OX40
expression since by 4 dpi approximately 5% of CD44hi2W1S:I-
Ab+CD4+ T cells expressed this receptor. These data were notably
different to that described for TCR transgenic T cells, where
OX40 was expressed by all the antigen-specific cells [5, 17, 18].
Following Lm-2W infection, three subsets of 2W1S-specific CD4+
T cells have been elegantly described [19]: CXCR5−PD-1−T-
bet+ effector T cells (where PD-1 is programmed death-1),
CXCR5+PD-1−Bcl-6+ cells that give rise to central memory cells
and CXCR5+PD-1+Bcl-6+ TFH cells. Expression of CD25 can be
used at 3 dpi to identify the CXCR5−PD-1−T-bet+ effector T-cell
subset [20]. Strikingly, the majority (>70%) of CD25+ 2W1S-
specific T cells at 3 dpi expressed OX40 and accounted for the
majority (>70%) of theOX40-expressing CD44hi2W1S:I-Ab+CD4+
T cells (Fig. 1E–G). By 7 dpi, no OX40 expression was detected
on CD44hi2W1S:I-Ab+ CD4+ T cells (Fig. 1C and D), includ-
ing the TFH population. Since OX40 signals have been impli-
cated in TFH formation and survival [8], we investigated whether
OX40+ cells co-expressed markers of TFH cells. Expression of Bcl-
6 was detected from 4 dpi and although only a fraction of the
CD44hi2W1S:I-Ab+CD4+ T cells expressed OX40 at this time, a
minority of the cells co-expressed Bcl-6 (Supporting Information
Fig. 1). Therefore, whilst OX40 is expressed mostly by 2W1S-
specific CD4+ T cells with an effector phenotype, a subset of Bcl-
6-expressing 2W1S-specific CD4+ T cells do also express OX40.
To further investigate whether OX40 signals were required for
the formation of TFH cells in the response to Lm-2W, mice defi-
cient in both OX40 and CD30were used, since there may be redun-
dancy in these signalling pathways [8]. WT and CD30−/−OX40−/−
mice were immunised with Lm-2W and then analysed at 7 dpi.
An overall decrease in the number of CD44hi2W1S:I-Ab+CD4+
T cells (Supporting Information Fig. 2; p = 0.0317; median
for WT: 52 331, CD30−/−OX40−/−: 21 975) resulted from less
CXCR5− effector cells (p = 0.0159; median for WT: 27 164,
CD30−/−OX40−/−: 8103) consistent with decreased survival,
however generation of TFHwas not impaired (p= 0.5556; median
C© 2014 The Authors. European Journal of Immunology published by
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Figure 1. Blockade of OX40:OX40L interac-
tions does not affectmemoryCD4+ T-cell sur-
vival. WTmice were immunised with Lm-2W
and after 4 weeks given blocking anti-OX40L
or control Abs twice weekly for 4 weeks.
(A) Detection of CD44hi2W1S:I-Ab+CD4+
T cells. Plots are gated on CD3+
B220−CD11b−CD11c− followed by CD4+CD8− ,
CD44hi2W1S:I-Ab+ T cells. (B) Enumeration
of CD44hi2W1S:I-Ab+ CD4+ memory T cells
in mice receiving either anti-OX40L or
control IgG Abs. (C) Expression of OX40
on 2W1S:I-Ab+CD4+ T cells at d2, d3,
d4, d7 and d28 post-immunisation with
Lm-2W, 4 hours and 4 days post-secondary
challenge, and on Foxp3+CD4+ Treg cells.
(D) Percentage of CD44hi 2W1S:I-Ab+ CD4+
T cells expressing OX40 at d3, d4 and d7
post-immunisation. (E) Expression of CD25
and OX40 on 2W1S:I-Ab+ CD4+ T cells
at 3 dpi. (F) Percentage of OX40− and
OX40+CD44hi2W1S:I-Ab+CD4+ T cells that
express CD25. (G) Percentage of CD25− and
CD25+CD44hi2W1S:I-Ab+CD4+ T cells that
express OX40. (A, C) Plots are representative
of 6 mice pooled from two independent
experiments. (B, D, F, G) Data are pooled
from two independent experiments, each
data point represents one mouse. Bars show
medians. Mann–Whitney test, *p < 0.05, NS
= non-significant.
for WT: 2850, CD30−/−OX40−/−: 3430), indicating that the gen-
eration of these cells did not require OX40 signals.
Although memory phenotype CD4+ T cells have been shown
to express OX40, amongst the memory CD44hi2W1S:I-Ab+CD4+
T-cell population no OX40 expression was detected. The unim-
paired survival of these cells when OX40L signals were blocked
is likely explained by a lack of OX40 expression by the antigen-
specific CD4+ T cells at this time. These cells could rapidly up-
regulate OX40 expression upon challenge in vivo with 2W1S
peptide (Fig. 1C) as previously described [2]. Here, the vast major-
ity of 2W1S:I-Ab+CD4+ T cells expressed OX40, indicating that
expression at this stage was not restricted to the effector sub-
set. Similarly, if Lm-2W-infected mice were challenged at 7 dpi
with 2W1S peptide, OX40 was rapidly expressed by almost all
2W-specific CD4+ T cells (Supporting Information Fig. 3). These
data show that OX40 expression by an endogenous polyclonal
antigen-specific population of CD4+ T cells is very tightly regu-
lated temporally and not uniformly expressed amongst responding
cells in a primary response. Upon re-encounter of antigen, OX40
is more broadly expressed.
Agonistic anti-OX40 Abs at challenge drive effector
T-cell expansion
Although the survival of 2W1S-specific cells in the memory phase
of the response was OX40 independent, the rapid expression of
OX40 within hours of seeing cognate antigen again prompted us
to test the effect of OX40 ligation at this time. Provision of ago-
nistic anti-OX40 Abs [6] on the day of challenge resulted in sig-
nificantly more (approximately 6.4-fold) CD44hi2W1S:I-Ab+CD4+
T cells 4 days later (Fig. 2A; p = 0.0079; median for con-
trol: 164 070, anti-OX40: 1 055 000). The majority of these
2W1S:I-Ab+CD4+ T cells were CXCR5−PD-1− effector CD4+ T cells
[19] and the percentage of CXCR5+PD-1+ TFH-cell population
significantly reduced (Fig. 2B–D). However, total numbers of TFH
cells were comparable, indicating that OX40 ligation had specif-
ically expanded effector 2W1S-specific cells (Fig. 2E; p = 0.222;
median for control: 8712, anti-OX40: 6673). If provision of anti-
OX40 Abs was delayed until the day after challenge, no significant
effect on the number of 2W1S:I-Ab+CD4+ T cells was detected,
indicating that as with a primary response, expression of OX40
was rapidly lost by the 2W1S:I-Ab+CD4+ T cells (Fig. 2F; p =
0.0541; median for control: 250 936, anti-OX40: 379 040). To
investigate whether the reduced percentage of TFH cells impacted
the ability to sustain GCs, sections of spleen at day 4 post-challenge
were stained for Bcl-6, the key transcription factor expressed by
GC B cells and TFH cells. Despite no difference in absolute number
of TFH cells, spleens from anti-OX40-treated mice were consider-
ably larger than that of control mice resulting in less TFH cells per
unit area. In mice given anti-OX40 Abs, fewer GCs per unit area
of spleen were detected, suggesting that changes to the balance
of the T-cell response had impacted the ability to sustain these
structures (Fig. 2G–I).
C© 2014 The Authors. European Journal of Immunology published by
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Figure 2. Ligation of OX40 upon
challenge enhances memory cell
expansion and skews phenotype
towards T effector memory. Secondary
lymphoid tissues were analysed from
mice receiving agonistic anti-OX40 or
control IgG Abs after challenge. (A) Enu-
meration of CD44hi2W1S:I-Ab+CD4+
T cells givenAbs on the day of challenge.
Percentage of CD44hi2W1S:I-Ab+CD4+
T cells that are (B) CXCR5+PD-1+ TFH
cells or (C) CXCR5−PD-1− effector cells.
(D) Expression pattern of CXCR5 and
PD-1 by CD44hi2W1S:I-Ab+CD4+ T cells.
(E) Total number of CD44hi2W1S:I-
Ab+CD4+ CXCR5+ PD-1+ TFH cells.
(F) Enumeration of CD44hi2W1S:I-Ab+
CD4+ T cells from mice given Abs the
day after challenge. (G) Immunofluo-
rescence staining of spleen sections
DAPI (grey) and expression of Bcl-6
(green), CD3 (blue) and CD4 (red) shown.
Magnification 25×, scale bar represents
100 μm. Confocal images are represen-
tative of five mice. (H) Area of Bcl-6+
germinal centre (GC) per 1000 μm2
spleen. (I) Absolute number of GCs per
100000 μm2 spleen. (A–C, E, H, I) Data
are pooled from two independent
experiments, each data point repre-
sents one mouse. Bars show medians.
(D) Plots are representative of 6 mice
pooled from two independent experi-
ments. Mann–Whitney test, *p < 0.05,
NS = non-significant.
Ligation of OX40 drives effector T-cell formation at the
expense of GCs in a primary response
OX40 expression by 2W1S-specific cells was tightly restricted to a
brief window of time associated with antigen exposure and pro-
liferation. Since OX40 ligation at challenge caused the expan-
sion of only the effector memory subset, we sought to investigate
the effects of OX40 ligation during a primary response. Previ-
ously, agonistic anti-OX40 Abs have dramatically enhanced the
numbers of TCR transgenic T cells [6, 21]. Mice were infected with
Lm-2W, then given agonistic anti-OX40 Abs at 1 dpi and analysed
at 7 dpi. Provision of anti-OX40 Abs resulted in approximately
5.5-fold more CD44hi2W1S:I-Ab+CD4+ T cells (Fig. 3A; p =
0.0006; median for controls: 57 710, anti-OX40: 316 688). In
contrast, provision of the blocking anti-OX40L Abs at 1 and 3
dpi approximately halved the number of CD44hi2W1S:I-Ab+CD4+
T cells at 7 dpi (Fig. 3B; p = 0.0041; median for control: 75 684,
anti-OX40L: 34 167). As detected at challenge, with anti-OX40,
the CD44hi2W1S:I-Ab+CD4+ T cells were heavily skewed towards
CXCR5− effector T cells. Furthermore, anti-OX40, but not anti-
OX40L, Abs dramatically reduced the percentage of the 2W1S-
specific cells with a TFH-cell phenotype (Fig. 3C–E; p = 0.0006;
median for control: 6.6%, anti-OX40: 0.24%). Analysis of total
numbers of TFH cells confirmed these cells were almost absent in
anti-OX40-treated mice (Fig. 3F). Therefore, unlike at challenge
where TFH cell numbers appeared undiminished, anti-OX40 Abs
during priming result in the expansion of effector cells and the
loss of the TFH-cell population.
Amongst CD44hi2W1S:I-Ab+CD4+ T cells after exposure to Lm-
2W, expression of T-bet is restricted to the CXCR5− effector T cells
[19] (Fig. 3G). To further demonstrate that OX40 ligation caused
the accumulation of the effector subset, we checked expression
of T-bet amongst CD44hi2W1S:I-Ab+CD4+ T cells. Ligation of
OX40 resulted in the vast majority of 2W-specific CD4+ T cells
expressing T-bet at 7 dpi (Fig. 3G and H; control vs. anti-OX40:
p= 0.0067; median for controls: 81%, anti-OX40: 99%; control vs.
anti-OX40L: p = 0.0167; median for anti-OX40L: 56.9%). Finally,
given the loss of the TFH-cell population, sections of spleen taken
at 7 dpi were stained for expression of Bcl-6 to assess effects
on GCs (Fig. 3I). Whilst GCs were evident in control mice, in
mice given agonistic anti-OX40 no clusters of Bcl-6+ cells were
detected. The detection of IgG2a+ plasma cells indicated that a
C© 2014 The Authors. European Journal of Immunology published by
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Figure 3. Therapeuticmanipulation of OX40:OX40L interactions impact on the size and phenotype of the primary 2W1S:I-Ab+CD4+ T-cell response.
Analysis of CD44hi2W1S:I-Ab+CD4+ T cells at 7 dpi frommice given anti-OX40, anti-OX40L or control IgG Abs. (A) Enumeration of CD44hi2W1S:I-Ab+
CD4+ T cells in spleen at 7 dpi in mice given anti-OX40 Abs; or (B) anti-OX40L Abs. (C) Percentage of CD44hi2W1S:I-Ab+CD4+ cells that are
CXCR5+PD-1+ TFH cells following treatmentwith anti-OX40 or (D) anti-OX40L Abs. (E) Representative CXCR5 and PD-1 expression on CD44hi2W1S:I-
Ab+CD4+ T cells inmice given control IgG, anti-OX40 or anti-OX40L. (F) Total numbers of CD44hi2W1S:I-Ab+CD4+CXCR5+PD-1+ TFH cells frommice
receiving control IgG, anti-OX40 or anti-OX40L Abs. (G) Representative CXCR5 and T-bet expression on CD44hi 2W1S:I-Ab+ CD4+ T cells in mice
given control IgG or anti-OX40. (H) Percentage of CD44hi2W1S:I-Ab+CD4+ T cells expressing T-bet in mice receiving control IgG, anti-OX40 Abs or
anti-OX40L. (I) Immunofluorescence staining of spleen sections from 7 dpi, DAPI (grey) and expression of Bcl-6 (green), CD3 (blue) and CD4 (red)
shown, and (J) DAPI (grey) and expression of IgG2a (green) and B220 (red) shown. Magnification 25×, scale bar represents 100 μm. Confocal images
are representative of five mice (I) or two mice (J). (A–D, F and H) Data are pooled from two independent experiments, each data point represents
one mouse. Bars show medians. (E, G) Plots are representative of 6 mice pooled from two independent experiments. Mann–Whitney test, *p <
0.05, NS = non-significant.
B-cell response with switching to Th1 Ab isotypes had been ini-
tiated (Fig. 3J) consistent with previous data showing GCs are
not required for initial Ab switching [22]. These data show strong
parallels to the recent study of anti-OX40 Abs in the response
to lymphocytic choriomeningitis virus (LCMV). A key difference
is that in this study, TCR transgenic T cells that homogenously
express OX40 during priming were used. Ligation of OX40 caused
up-regulation of Blimp-1 repressing TFH-cell formation. However,
C© 2014 The Authors. European Journal of Immunology published by
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in the response to Lm-2W described here, expression of OX40 is
restricted to cells with an effector phenotype, which then specif-
ically benefit from Ab-ligation of the receptor. Whilst there is no
previous evidence for the OX-86 clone depleting OX40+ cells, we
assessed the numbers of Treg cells, which constitutively express
OX40, in control and anti-OX40-treated mice. No significant dif-
ferences were detected in the number of FoxP3+2W1S:I-Ab+CD4+
T cells or total CD4+FoxP3+ T cells (Supporting Information
Fig. 4), arguing against in vivo depletion of OX40+ cells by the
anti-OX40 Abs.
These data indicated that Ab-mediated ligation of OX40
during priming caused the specific expansion of OX40+2W1S:I-
Ab+ CD4+ T cells, which gave rise to the expanded CXCR5− effec-
tor T-cell pool. Consistent with this, administration of anti-OX40
Abs at 4 dpi with Lm-2W, a time point when the CD44hi2W1S:I-
Ab+ CD4+ T cells had lost expression of OX40, resulted in only a
verymodest increase in CD44hi2W1S:I-Ab+ CD4+ T cells (Support-
ing Information Fig. 5; p = 0.0047; median for control: 46 097,
agonistic anti-OX40: 59 423) and the percentage of TFH cells was
not affected.
Ligation of OX40 results in an enhanced effector
memory T-cell pool
Given the increased effector T-cell expansion, anti-OX40 Abs likely
enhanced the effector rather than central memory pool. Previ-
ous studies with OX40-deficient OTII T cells indicated that OX40
signals were important for effector rather than central memory
generation [23]. Recent data from a humanOX40-deficient patient
reported a reduced proportion of effector memory CD4+ T cells
[24]. To assess the memory population after OX40 ligation during
priming, mice were immunised as before, treated with control or
agonistic anti-OX40 Abs at 1 dpi and at 28 dpi given 2W1S peptide
in vivo and analysed 4 hours later. In vivo peptide stimulation was
used to functionally define effector memory cells as those able to
make both IL-2 and IFN-γ, and central memory cells as those mak-
ing only IL-2 [20]. In mice treated with anti-OX40 Abs, there was a
significant increase in the percentage of CD44hi2W1S:I-Ab+CD4+
T cells defined functionally as effector memory cells (Fig. 4A and
C). The enhanced frequency of effector memory cells was accom-
panied by a significant decrease in the central memory population
(Fig. 4B; p = 0.013), therefore ligation of OX40 during priming
had significantly skewed the resulting memory population. Sur-
prisingly, the total numbers of CD44hi2W1S:I-Ab+CD4+ T cells
between control and anti-OX40-treated mice, in the secondary
lymphoid tissue at least, were now comparable, indicating a dra-
matic contraction of the primary response and normal homeostatic
regulation of the memory pool size (Fig. 4D).
Intrinsic expression of T-bet is not required for
effector T-cell expansion
Ligation of OX40 has been found to induce T-bet mRNA [21].
Expression of T-bet is thought to block Th2 differentiation, rather
Figure 4. Ligation of OX40 alters the phenotype but not the
number of 2W1S:I-Ab+ memory CD4+ T cells. Analysis of the
CD44hi2W1S:I-Ab+ memory CD4+ T cells. The percentages of the mem-
ory CD4+ T-cell population with (A) effector memory (IL-2+IFN-γ+) or
(B) centralmemory (IL-2+IFN-γ−) phenotype are shown. (C) Flow cytom-
etry staining of cytokines IL-2 and IFN-γ following in vivo stimulation
with 2W1S peptide at 28 dpi. (D) Total number of CD44hi2W1S:I-Ab+
CD4+ memory T cells recovered after in vivo peptide stimulation. (A,
B, D) Data have been pooled from 2 independent experiments, each
data point represents one mouse. Bars show medians. (C) Plots are
representative of 6 mice pooled from two independent experiments.
Mann–Whitney test, *p < 0.05, NS = non-significant.
than promote Th1 formation [25]. To investigate whether the
phenotypic changes observed with OX40 ligation were dependent
upon endogenous T-bet expression, WT and Rag1-Cre Tbx21 fl/fl
Rosa26-tdRFPwere immunised with Lm-2W, given control or anti-
OX40 Abs at 1 dpi and analysed at 7 dpi. In Rag1-Cre Tbx21 fl/fl
Rosa26-tdRFP mice given control IgG, the response was compara-
ble to WT mice (Fig. 5A). Provision of anti-OX40 Abs resulted in
significantly increased expansion of the CD44hi2W1S:I-Ab+CD4+
T cells (Fig. 5B; p = 0.005; median for control: 22 405, anti-OX40:
68 405) with again the loss of TFH cells (Fig. 5C; p = 0.0344) and
the skewing towards CXCR5− cells (Fig. 5D; CXCR5−, p = 0.005;
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Figure 5. Intrinsic expression of T-bet is not required for the effects of agonistic anti-OX40 Abs. WT and Rag1-Cre Tbx21 fl/fl Rosa26-tdRFP were
immunised with Lm-2W and given control IgG or anti-OX40 Abs at 1 dpi and then analysed at 7 dpi. (A) Staining of CD44hi2W1S:I-Ab+CD4+ T cells
for CXCR5 and PD-1 in Rag1-Cre Tbx21 fl/fl Rosa26-tdRFP. (B) Total numbers of CD44hi2W1S:I-Ab+CD4+ T cells in Rag1-Cre Tbx21 fl/fl Rosa26-
tdRFP mice. Percentage of (C) TFH cells and (D) CXCR5− and CXCR5+ CD44hi2W1S:I-Ab+CD4+ T cells from Rag1-Cre Tbx21 fl/fl Rosa26-tdRFP mice.
(E) Expression of T-bet by CD44hi2W1S:I-Ab+CD4+ T cells. (A, E) Plots are representative of 5 mice pooled from two independent experiments.
(B–D) Data have been pooled from two independent experiments, each data point represents one mouse. Bars showmedians. Mann–Whitney test,
*p < 0.05, NS = non-significant.
CXCR5+, p = 0.005). Staining for expression of T-bet confirmed
its absence in the Tbx21 fl/fl mice, demonstrating that the effects
of anti-OX40 Abs on T-cell phenotype do not require T-bet expres-
sion, consistent with experiments with non-antigen-specific CD4+
T cells [21].
Altered OX40 expression in a Th2 response, but still
effector cell expansion upon ligation
To assess the response when 2W1S peptide was encountered
within a different context, mice were immunised with 2W1S
peptide precipitated with alum. This resulted in different kinet-
ics of OX40 expression, with expression of OX40 by 2W1S-specific
cells initiated at 4 dpi, andmaintained until at least 9 dpi (Fig. 6A).
Furthermore, at 9 dpi, expression was not exclusively confined to
CXCR5− cells, although very little was detected on the TFH-cell
population (Fig. 6B and C). Ligation of OX40 had the same effect
as in the Lm-2W infection, with the dramatic expansion of the
2W1S-specific CD4+ T cells (Fig. 6B and D; p = 0.003; median for
control: 17 721, anti-OX40: 210 626). Again, this expansion was
specific to the CXCR5− cells, which expanded significantly, whilst
although the percentage of TFH cells was much reduced, abso-
lute numbers were not significantly affected (Fig. 6E–H) and the
number of GC structures appeared comparable (data not shown).
Therefore, whilst the manner in which the antigen is encoun-
tered changed the pattern of OX40 expression by responding cells,
enhanced OX40 signalling again expanded specifically the effector
population.
Discussion
In this report, we show that for an endogenous polyclonal CD4+
T-cell population responding to Listeria infection, OX40 expres-
sion is induced during priming largely on responding antigen-
specific T cells with an effector phenotype. Modulation of OX40
through blocking OX40L, ligation of OX40 or mice deficient in
OX40, substantially affected the effector subset of 2W1S-specific
CD4+ T cells. Although expression of OX40 has been previously
linked to the persistence of GCs and TFH cells [8], within this
infection model, the formation of TFH cells did not require OX40
signals and ligation of OX40 did not enhance their number.
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Figure 6. OX40 expression is prolonged with alum adju-
vant, but ligation still causes effector cell expansion. Mice
were immunisedwith alum-precipitated 2W1S peptide and
given anti-OX40 Abs or control IgG at 1 dpi. (A) Representa-
tive plots of OX40 expression on CD44hi2W1S:I-Ab+CD4+
T cells at d3, d4 and d9 post-immunisation. Plots are
representative of 3 mice. (B) Staining of CD44hi2W1S:I-
Ab+CD4+ T cells for CXCR5 and PD-1 by flow cytome-
try at 9 dpi. (C) Percentage of CXCR5−, CXCR5+ and TFH
cells amongst CD44hi2W1S:I-Ab+CD4+ T cells, or all of
CD44hi2W1S:I-Ab+CD4+ T cells expressing OX40 at 9 dpi.
(D) Enumeration of CD44hi2W1S:I-Ab+CD4+ T cells at
9 dpi. (E) Percentage of TFH cells amongst CD44hi2W1S:I-
Ab+CD4+ T cells. (F) Percentage of CD44hi2W1S:I-Ab+CD4+
T cells that are CXCR5− or CXCR5+. Total number of
CD44hi2W1S:I-Ab+CD4+ T cells that are TFH cells (G) or
CXCR5− (H). (A and B) Plots are representative of 5 mice
pooled from two independent experiments unless stated.
(C–H) Data have been pooled from two independent exper-
iments, each data point represents one mouse. Bars
show medians. Mann–Whitney test, *p < 0.05, NS = non-
significant.
Initially, we sought to analyse expression of OX40 by endoge-
nous polyclonal CD4+ T cells, utilising MHC-II tetramers to build
upon previous investigations reliant upon TCR transgenic T cells.
In these studies, OX40 expression was induced within 24–48 hours
and maintained for several days [1, 5, 6]. Chronic LCMV infection
will maintain antigen-specific CD4+ T-cell expression of OX40 for
weeks in contrast to acute infection [17]. Therefore, the kinet-
ics of OX40 expression reflects the nature of the antigen and the
manner in which it is encountered. The brief window of OX40
expression in the primary response to Lm-2W likely reflects the
acute nature of this attenuated infection and its rapid clearance.
Clearly, the other 2W1S-specific subsets can be induced to express
OX40 upon re-encounter of the peptide. Immunisation with alum-
precipitated 2W1S-peptide resulted in a longer window of OX40
expression by the same endogenous antigen-specific population.
In all these situations, Ab-ligation of OX40 specifically enhanced
the effector subset of 2W1S-specific cells. It was recently shown
in LCMV infection that Ab-ligation of OX40 greatly enhanced the
effector subset and caused the loss of TFH cells, an observation
linked to enhanced Blimp-1 expression, thought to block Bcl-6
and TFH formation [18]. In this interesting study, the authors
propose that ligation of OX40 drives enhanced IL-2 expression,
driving Blimp-1 expression and STAT5 activation and inhibiting
TFH-cell formation. In the primary response to Lm-2W, the major-
ity of the cells that express OX40 already appear committed to an
effector phenotype, indicating that in this situation, OX40 ligation
promotes the proliferation and survival of this effector popula-
tion rather than impaired differentiation of the TFH cells. This
expansion is also not dependent upon endogenous T-cell expres-
sion of T-bet. Impaired TFH-cell differentiation may well occur
when OX40 is ligated upon re-exposure to antigen, where 2W1S-
specific CD4+ T cells rapidly up-regulate OX40 regardless of their
effector or TFH-cell phenotype. Notably, total numbers of TFH
cells are not altered when OX40 is ligated at challenge, whilst in a
primary response the effector cell expansion is accompanied by the
complete loss of the TFH-cell population. These data suggest that
during the primary response, the enhanced effector cell expansion
is accompanied by the out-competition of the TFH cells, perhaps
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due to a loss of niches within the tissue. Alternatively, the high
levels of IFN-γ produced following Ab-ligation of OX40 may cause
the loss of TFH cells and GCs, analogous to CD70 transgenic mice
[26].
Previous studies have concluded that signals through OX40 are
important for persistence of TFH cells and thus the formation of
T-dependent humoral responses and GCs [8]. Boettler et al. have
also shown that control of chronic LCMV through high-affinity
Ab is dependent upon OX40 [17]. Therefore, it might have been
anticipated that provision of anti-OX40 Abs would enhance the
generation of TFH cells, however this clearly does not occur in
our hands or others [18]. The injection of large quantities of anti-
OX40 Abs may deregulate the normal in vivo control of OX40 sig-
nals and thus normal functions of OX40 signals may be obscured.
However, in the response to Lm-2W at least, we show that signals
through OX40 are not required to generate a TFH-cell population.
Furthermore, this population did not express OX40 in WT mice at
a time when established GC structures were evident. Should TFH
cells require OX40 signals for persistence, presumably these cells
should express OX40, which may occur in situations of chronic
infection and abundant antigen. This model would also require
OX40L expression by a GC-resident cell type, which has not been
clearly described. In the Lm-2Wmodel, TFH cells are clearly reliant
upon B-cell-derived ICOS ligand (ICOSL) for their generation [19].
Therefore, amongst CD4+ T-cell subsets, distinct requirements for
costimulatory molecules exist, which are also likely different for
naive and memory cells.
Whilst there are considerable data supporting a role in the
expansion and survival of CD4+ T cells during a primary response,
direct evidence for memory CD4+ T-cell survival is lacking, par-
ticularly under physiological conditions. These studies were also
prompted by efforts to understand the mechanisms by which
ROR-γ+ ILCs might support memory CD4+ T-cell survival [10].
Infection of ROR-γ−/− mice with Lm-2W results in a normal pri-
mary response, but a significantly reduced memory cell pool, con-
sistent with the theory that ROR-γ+ ILCs supported memory cells
through provision of OX40L. To test this, we blocked OX40L sig-
nals in vivo and found that the survival of 2W1S-specific memory
CD4+ T cells was not significantly affected. It remains possible
that blockade of OX40L signals was incomplete or was not main-
tained for sufficient time to see significant changes in memory cell
numbers. As we were unable to detect OX40 expression on these
memory CD4+ T cells directly ex vivo, this would seem an unlikely
mechanism through which survival signals are mediated.
Since agonistic anti-OX40 Abs are being used clinically, these
data clarify that the cost of enhanced effector T-cell responses
may be the loss of high-affinity Ab generated though the GC.
Agonist Abs to OX40 have been used in a variety of tumour
models with varying success and also in phase I clinical tri-
als [2, 27]. Ligation of OX40 clearly dramatically enhances the
number of effector CD4+ T cells, which may enhance tumour
clearance. Stimulation through OX40 is also being considered as
a means of enhancing vaccine responses [2]. Our data suggest
that, depending on the context of the response, this approach
may be less successful if high-affinity Ab responses are desired.
Furthermore, despite the dramatic enlargement of the effector T-
cell pool, numbers of antigen-specific T cells at the memory phase
of the response were comparable between treated and control
mice, perhaps due to poor conversion to memory cells as observed
when non-physiological numbers of TCR transgenic T cells are
analysed [15]. In summary, our data clarify the importance of
OX40 signals for physiological responses and provide data on the
likely effects of clinical manipulation of OX40 signals in patients.
Materials and methods
Mice
Mice used were C57BL/6 (obtained from Harlan) and Rag1-Cre
Tbx21 fl/fl Rosa26-tdRFP (Tbx21 fl/fl mice were kind gift from
Dr. Steve Reiner to Dr. Marc Veldhoen). CD30−/−OX40−/− mice
[8] were compared to C57Bl/6 mice bred in-house. Animals were
used in accordance with Home Office guidelines at the University
of Birmingham and Babraham Institute, Biomedical Services Units.
Immunisation
Mice were immunised intravenously (i.v.) with 107 ActA-deficient
Lm-2W (kind gift from Dr. Marc Jenkins) as described [16]. Bac-
teria were grown at 37°C in a shaking incubator to concentration
OD600 = 0.1 in Luria-Bertani broth supplemented with 20 μg/mL
chloramphenicol. To generate a Th2 response, mice were immu-
nised intra-peritoneally (i.p.) with 100 μg aluminium hydroxide
precipitated 2W1S peptide. For in vivo peptide challenge, mice
were injected i.v. with 100 μg 2W1S peptide with 2.5 μg LPS, and
secondary lymphoid tissues were harvested 4 hours later for flow
cytometric analysis.
Ab injection
Blocking mAbs against mouse OX40L (clone RM134L) were
prepared as described previously [28]. Control rat IgG was pur-
chased from Sigma-Aldrich. Mice were injected i.p. with 0.25 mg
anti-OX40L or control rat IgG. For memory cell experiments, mice
were injected twice weekly for 4 weeks at 28 dpi. To assess effect
of blocking OX40 on primary responses, mice were injected 1 and
3 dpi. Mice were injected i.p. with 100 μg anti-OX40 (clone OX86)
on the day of challenge for memory experiments or as stated.
Flow cytometry
For tetramer staining, cells from secondary lymphoid tissue
were pooled and stained for 1 hour at room temperature with
10 nm PE-conjugated 2W1S:I-Ab. For in vivo peptide experiments,
10 μg/mL brefeldin A was added at this stage. All cell surface
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staining was done at 4°C for 30 min, with the exception of CXCR5
that was stained for 1 hour at room temperature. Enrichment for
2W1S:I-Ab-specific T cells was performed at d2, d3, d4 and d28, as
described previously, using anti-PE MicroBeads (Miltenyi Biotech)
and MACS enrichment [29]. Enriched and run-through fractions
were stained with the same cocktail of surface Abs to enable cal-
culation of cell frequencies. Samples were run using an LSR11
(BD Biosciences) and analysed using FlowJo software (Tree Star).
For intracellular cytoplasmic staining, cells were fixed and perme-
abilised with Cytofix/Cytoperm Plus (BD Biosciences) according to
manufacturer’s instructions. Intracellular cytokines were stained
with IL-2 488 and IFN- γ PECy7 (BD Bioscience).
Immunofluorescence and image analysis
Tissues sections from experimental mice were cut and stained
as described previously [10]. Sections were counterstained with
DAPI (Invitrogen) and mounted using ProLong Gold (Invitrogen).
Slides were analysed on an LSM 510 Meta confocal (Zeiss). For
calculations of number and size of GCs, tile scans of whole spleen
sections were made, and all Bcl-6+ cell clusters were identified
and the area was calculated using LSM (Zeiss).
Statistics
Data were analysed using GraphPad Prism (version 5.01). Non-
parametric Mann–Whitney test was used to determine significance
that was set at p  0.05. Median values were calculated and used
in all analyses.
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